Vedolizumab-5028: A Retrospective UK Chart Review of Early Vedolizumab (Entyvio®) Experience: Real World Treatment, Effectiveness and Safety in Inflammatory Bowel Disease (IBD) First published 11/03/2016 Last updated 21/11/2024 EU PAS number:EUPAS12537 Study Finalised